CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. High threat of substitutes
3.3.4. Moderate threat of new entrants
3.3.5. Moderate intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increasing demand for nanozymes in biomedical industry
3.4.1.2. Benefiets of nanozymes
3.4.2. Restraints
3.4.2.1. Presence of alternative to nanozymes
3.4.3. Opportunities
3.4.3.1. Increasing demand for nanozymes from food and beverages industry
3.5. COVID-19 Impact Analysis on the market
3.6. Key Regulation Analysis
3.7. Patent Landscape
3.8. Pricing Analysis
3.9. Value Chain Analysis
CHAPTER 4: NANOZYMES MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Active Metal Centre Mimic
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Functional Mimic
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Nanocomposite
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. 3D Structural Mimic
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: NANOZYMES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Healthcare
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Chemical
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Agriculture
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: NANOZYMES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Type
6.2.3. Market size and forecast, by Application
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Type
6.2.4.1.3. Market size and forecast, by Application
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Type
6.2.4.2.3. Market size and forecast, by Application
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Type
6.2.4.3.3. Market size and forecast, by Application
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Type
6.3.3. Market size and forecast, by Application
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Type
6.3.4.1.3. Market size and forecast, by Application
6.3.4.2. France
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Type
6.3.4.2.3. Market size and forecast, by Application
6.3.4.3. Italy
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Type
6.3.4.3.3. Market size and forecast, by Application
6.3.4.4. Spain
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Type
6.3.4.4.3. Market size and forecast, by Application
6.3.4.5. UK
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Type
6.3.4.5.3. Market size and forecast, by Application
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Type
6.3.4.6.3. Market size and forecast, by Application
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Type
6.4.3. Market size and forecast, by Application
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Type
6.4.4.1.3. Market size and forecast, by Application
6.4.4.2. India
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Type
6.4.4.2.3. Market size and forecast, by Application
6.4.4.3. Japan
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Type
6.4.4.3.3. Market size and forecast, by Application
6.4.4.4. South Korea
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Type
6.4.4.4.3. Market size and forecast, by Application
6.4.4.5. Australia
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Type
6.4.4.5.3. Market size and forecast, by Application
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Key market trends, growth factors and opportunities
6.4.4.6.2. Market size and forecast, by Type
6.4.4.6.3. Market size and forecast, by Application
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Type
6.5.3. Market size and forecast, by Application
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Type
6.5.4.1.3. Market size and forecast, by Application
6.5.4.2. South Africa
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Type
6.5.4.2.3. Market size and forecast, by Application
6.5.4.3. South Arabia
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Type
6.5.4.3.3. Market size and forecast, by Application
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Type
6.5.4.4.3. Market size and forecast, by Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1. Profacgen
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.2. Max Systems LLC.
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.3. FutureX Industries
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.4. Nano medichem
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.5. Emergene Agrinovo Private Limited
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
TABLE 01. GLOBAL NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 02. NANOZYMES MARKET FOR ACTIVE METAL CENTRE MIMIC, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 03. NANOZYMES MARKET FOR FUNCTIONAL MIMIC, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 04. NANOZYMES MARKET FOR NANOCOMPOSITE, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 05. NANOZYMES MARKET FOR 3D STRUCTURAL MIMIC, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 06. GLOBAL NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 07. NANOZYMES MARKET FOR HEALTHCARE, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 08. NANOZYMES MARKET FOR CHEMICAL, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 09. NANOZYMES MARKET FOR AGRICULTURE, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 10. NANOZYMES MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 11. NANOZYMES MARKET, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 12. NORTH AMERICA NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 13. NORTH AMERICA NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 14. NORTH AMERICA NANOZYMES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
TABLE 15. U.S. NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 16. U.S. NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 17. CANADA NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 18. CANADA NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 19. MEXICO NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 20. MEXICO NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 21. EUROPE NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 22. EUROPE NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 23. EUROPE NANOZYMES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
TABLE 24. GERMANY NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 25. GERMANY NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 26. FRANCE NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 27. FRANCE NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 28. ITALY NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 29. ITALY NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 30. SPAIN NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 31. SPAIN NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 32. UK NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 33. UK NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 34. REST OF EUROPE NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 35. REST OF EUROPE NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 36. ASIA-PACIFIC NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 37. ASIA-PACIFIC NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 38. ASIA-PACIFIC NANOZYMES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
TABLE 39. CHINA NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 40. CHINA NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 41. INDIA NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 42. INDIA NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 43. JAPAN NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 44. JAPAN NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 45. SOUTH KOREA NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 46. SOUTH KOREA NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 47. AUSTRALIA NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 48. AUSTRALIA NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 49. REST OF ASIA-PACIFIC NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 50. REST OF ASIA-PACIFIC NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 51. LAMEA NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 52. LAMEA NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 53. LAMEA NANOZYMES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
TABLE 54. BRAZIL NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 55. BRAZIL NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 56. SOUTH AFRICA NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 57. SOUTH AFRICA NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 58. SOUTH ARABIA NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 59. SOUTH ARABIA NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 60. REST OF LAMEA NANOZYMES MARKET, BY TYPE, 2021-2031 (REVENUE, $THOUSAND)
TABLE 61. REST OF LAMEA NANOZYMES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 62. PROFACGEN: KEY EXECUTIVES
TABLE 63. PROFACGEN: COMPANY SNAPSHOT
TABLE 64. PROFACGEN: PRODUCT SEGMENTS
TABLE 65. PROFACGEN: PRODUCT PORTFOLIO
TABLE 66. MAX SYSTEMS LLC.: KEY EXECUTIVES
TABLE 67. MAX SYSTEMS LLC.: COMPANY SNAPSHOT
TABLE 68. MAX SYSTEMS LLC.: PRODUCT SEGMENTS
TABLE 69. MAX SYSTEMS LLC.: PRODUCT PORTFOLIO
TABLE 70. FUTUREX INDUSTRIES: KEY EXECUTIVES
TABLE 71. FUTUREX INDUSTRIES: COMPANY SNAPSHOT
TABLE 72. FUTUREX INDUSTRIES: PRODUCT SEGMENTS
TABLE 73. FUTUREX INDUSTRIES: PRODUCT PORTFOLIO
TABLE 74. NANO MEDICHEM: KEY EXECUTIVES
TABLE 75. NANO MEDICHEM: COMPANY SNAPSHOT
TABLE 76. NANO MEDICHEM: PRODUCT SEGMENTS
TABLE 77. NANO MEDICHEM: PRODUCT PORTFOLIO
TABLE 78. EMERGENE AGRINOVO PRIVATE LIMITED: KEY EXECUTIVES
TABLE 79. EMERGENE AGRINOVO PRIVATE LIMITED: COMPANY SNAPSHOT
TABLE 80. EMERGENE AGRINOVO PRIVATE LIMITED: PRODUCT SEGMENTS
TABLE 81. EMERGENE AGRINOVO PRIVATE LIMITED: PRODUCT PORTFOLIO
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/